Monday, 30 May 2016 / TRUTH-OUT.ORG
  • The Elites and the Rise of Donald Trump

    Dean Baker: Donald Trump passed the threshold of committed delegates that gives him a lock on the Republican Party presidential nomination. It's worth considering what led to Trump's rise in the first place.

  • Congress Bows to the Chemical Lobby on Toxics Regulation

    New legislation would make it harder for states and the EPA to regulate toxic chemicals in toys, building materials and clothing, but President Obama still has a chance to veto.

Andrew Pollack

Andrew Pollack

Andy Pollack has covered the business and science of biotechnology since 2000.

He joined The New York Times in 1981, covering computers and telecommunications, after three years at The Dallas Times-Herald. He previously covered technology and other business while based in San Francisco from 1985 to 1992, Tokyo from 1992 to 1997 and Los Angeles from 1997 to 2000. He still works out of the Los Angeles bureau of The Times.

A native of Queens, New York, Andy earned a bachelor's degree from Princeton and a master’s degree in civil and environmental engineering from the Massachusetts Institute of Technology.

Other articles by this author

Scant Oversight of Drug Maker Leads to Fatal Meningitis Outbreak

By Andrew Pollack, Sabrina Tavernise and Denise Grady, The New York Times News Service | Report

India Orders Bayer to License a Patented Drug

By Andrew Pollack and Vikas Bajaj, The New York Times News Service | Report

Japanese Revisit Nuclear Zone While They Can

By Andrew Pollack, The New York Times News Service | Report

Tokyo Power to Compensate 50,000 Evacuees

By Keith Bradsher and Andrew Pollack, The New York Times News Service | Report

Japan Nuclear Disaster Put on Par With Chernobyl

By Andrew Pollack, Hiroko Tabuchi and Keith Bradsher, The New York Times News Service | Report

Millions Without Power After Japan Aftershock

By Andrew Pollack and Hiroko Tabuchi, The New York Times | Report
GET DAILY TRUTHOUT UPDATES
Optional Member Code

FOLLOW togtorsstottofb


Featured Videos

Andrew Pollack

Andrew Pollack

Andy Pollack has covered the business and science of biotechnology since 2000.

He joined The New York Times in 1981, covering computers and telecommunications, after three years at The Dallas Times-Herald. He previously covered technology and other business while based in San Francisco from 1985 to 1992, Tokyo from 1992 to 1997 and Los Angeles from 1997 to 2000. He still works out of the Los Angeles bureau of The Times.

A native of Queens, New York, Andy earned a bachelor's degree from Princeton and a master’s degree in civil and environmental engineering from the Massachusetts Institute of Technology.

Other articles by this author

Scant Oversight of Drug Maker Leads to Fatal Meningitis Outbreak

By Andrew Pollack, Sabrina Tavernise and Denise Grady, The New York Times News Service | Report

India Orders Bayer to License a Patented Drug

By Andrew Pollack and Vikas Bajaj, The New York Times News Service | Report

Japanese Revisit Nuclear Zone While They Can

By Andrew Pollack, The New York Times News Service | Report

Tokyo Power to Compensate 50,000 Evacuees

By Keith Bradsher and Andrew Pollack, The New York Times News Service | Report

Japan Nuclear Disaster Put on Par With Chernobyl

By Andrew Pollack, Hiroko Tabuchi and Keith Bradsher, The New York Times News Service | Report

Millions Without Power After Japan Aftershock

By Andrew Pollack and Hiroko Tabuchi, The New York Times | Report